Seagen Inc 's ability to collect accounts receivable sequentially worsen to 4.15, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Seagen Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 88 days, from 87 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 196 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1718, from overall ranking in the second quarter 2023 at 3067.

What is Receivable Turnover Ratio?
What is Seagen Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SGEN Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	29.75 %	33.79 %	23.63 %	28.94 %	25.72 %
Y / Y Revenue Change	27.11 %	21.37 %	21.87 %	22.87 %	20.34 %
Receivable Turnover Ratio (TTM)	4.15	4.18	4.28	4.29	4.35
SGEN's Total Ranking	# 1718	# 3067	# 419	# 897	# 1717
Accounts Receivable average collection period days	88	87	85	85	84
Seq. Receivable Change	7.77 %	18.21 %	-1.22 %	3.11 %	11.12 %
Seq. Revenue Change	7.42 %	16.18 %	-1.6 %	3.5 %	2.57 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 9
Healthcare Sector	# 197
Overall Market	# 1718

Receivable Turnover Ratio Statistics
High	Average	Low
0.79	0.54	0.4
(Sep 30 2020)		(Dec 31 2021)

SGEN Company Profile • Back to SGEN Efficiency Comparisons • Compare SGEN Receivables Turnover Ratio to its Competitors

Financial Statements
Seagen Inc 's Accounts Receivable	$ 632 Millions	Visit SGEN's Balance sheet
Seagen Inc 's Sales TTM	$ 2,300 Millions	Visit SGEN's Income Statement
Sources of SGEN's Revenues		Visit SGEN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SGEN's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SGEN's Growth Rates	SGEN's Roa	SGEN's Inventory Turnover Ratio	SGEN's Dividend Comparisons
SGEN's Profitability Ratios	SGEN's Roi	SGEN's Asset Turnover Ratio	SGEN's Dividend Growth
SGEN's Valuation Ratios	SGEN's Roe	SGEN's Financial Strength Ratios	SGEN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Neurometrix Inc	9.95	$ 6.431 Millions	$ 0.646 Millions
United Therapeutics Corporation	9.95	$ 2,204.300 Millions	$ 221.550 Millions
Tandem Diabetes Care Inc	9.95	$ 771.241 Millions	$ 77.545 Millions
Viemed Healthcare Inc	9.90	$ 169.777 Millions	$ 17.143 Millions
Merus N v	9.76	$ 45.674 Millions	$ 4.682 Millions
Editas Medicine Inc	9.75	$ 24.611 Millions	$ 2.524 Millions
Arbutus Biopharma Corp	9.56	$ 22.241 Millions	$ 2.325 Millions
Quidelortho Corp	9.56	$ 3,121.741 Millions	$ 326.650 Millions
The Pennant Group Inc	9.49	$ 523.602 Millions	$ 55.171 Millions
Femasys Inc	9.49	$ 1.093 Millions	$ 0.115 Millions
Irhythm Holdings Inc	9.40	$ 471.752 Millions	$ 50.163 Millions
Ngm Biopharmaceuticals Inc	9.37	$ 22.433 Millions	$ 2.393 Millions
Biolase Inc	9.36	$ 49.382 Millions	$ 5.276 Millions
Procyon Corporation	9.24	$ 4.684 Millions	$ 0.507 Millions
Tvardi Therapeutics Inc	9.20	$ 21.225 Millions	$ 2.308 Millions
Acorda Therapeutics Inc	9.18	$ 111.118 Millions	$ 12.106 Millions
Harmony Biosciences Holdings inc	9.09	$ 541.622 Millions	$ 59.598 Millions
Myomo Inc	9.08	$ 17.258 Millions	$ 1.901 Millions
Igc Pharma Inc	9.04	$ 1.343 Millions	$ 0.149 Millions
Talis Biomedical Corporation	9.04	$ 2.196 Millions	$ 0.243 Millions
Emmaus Life Sciences Inc	8.94	$ 28.460 Millions	$ 3.185 Millions
Inspire Medical Systems inc	8.90	$ 569.809 Millions	$ 63.988 Millions
Avid Bioservices Inc	8.90	$ 139.466 Millions	$ 15.678 Millions
Biodesix Inc	8.87	$ 44.026 Millions	$ 4.966 Millions
Sanara Medtech Inc	8.83	$ 61.677 Millions	$ 6.987 Millions
Insmed Inc	8.76	$ 277.639 Millions	$ 31.691 Millions
Scientific Industries Inc	8.74	$ 11.043 Millions	$ 1.264 Millions
Arcturus Therapeutics Holdings Inc	8.70	$ 296.237 Millions	$ 34.067 Millions
Immucell Corporation	8.69	$ 15.668 Millions	$ 1.803 Millions
Addus Homecare Corp	8.64	$ 1,028.360 Millions	$ 119.076 Millions

Date modified: 2026-08-29T17:24:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.